Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted priority review to the company’s supplemental ...
The end of the biggest World Cup ever is almost here. Following 100 matches, there are just four teams left and two more games to play. The tournament has been hosted by three countries: Mexico, ...
When Middle Tennessee hospitals need blood, most turn to nonprofit Blood Assurance. Here's an inside look at its intricate network that saves lives.
Tissue engineers are finding ways to grow living organs and tissues from cells, with the aim of replacing diseased and ...
A 76-year-old man presented with a 3-week history of binocular vertical diplopia.He denied change in vision, pain with eye ...
Completion of enrollment anticipated within 12 months GALILEO-3 is intended to support the registration of FLT201 in ...
Completion of enrollment anticipated within 12 monthsGALILEO-3 is intended to support the registration of FLT201 in the adult GD1 ...
Just as we redefined what is possible in cystic fibrosis, our ambition is to transform the future for people living with sickle cell disease and transfusion-dependent beta thalassemia. The remarkable ...
State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorder ...
Review shows majority of procedures offered alongside standard IVF not backed by reliable evidence ...
Please provide your email address to receive an email when new articles are posted on . In patients who had dryness with habitual lenses, most reported all-day comfort and clear vision with Infuse for ...
Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results